Skip to main content
TipRanks
Go Ultimate75% OFF

Steminent Biotherapeutics, Inc. (7729) Cash flow

Steminent Biotherapeutics, Inc. Cash Flow

TW:7729's free cash flow for Q2 2026 was NT$-111.94M. For the 2026 fiscal year, TW:7729's free cash flow was decreased by NT$-2.02M and operating cash flow was NT$-109.92M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
NT$ -132.31MNT$ -139.41MNT$ -114.81MNT$ -69.20MNT$ -55.11M
NT$ 3.84MNT$ -99.97MNT$ -28.56MNT$ -2.50MNT$ -548.00K
NT$ 422.52MNT$ -7.49MNT$ 441.95MNT$ -5.43MNT$ 245.42M
NT$ 499.18MNT$ 205.40MNT$ 451.86MNT$ 153.43MNT$ 230.56M
NT$ -140.07MNT$ -227.79MNT$ -142.52MNT$ -71.71MNT$ -55.71M

Currency in TWD

Steminent Biotherapeutics, Inc. Cash Flow

-200M0200M400M600M202020212022202320242025OperatingInvestingFinancing